interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Sofosbuvir; Velpatasvir; Voxilaprevir

Generic competition · all medicines · read 12 November 2026

Is there a generic of Sofosbuvir; Velpatasvir; Voxilaprevir, and who makes it?

Sofosbuvir; Velpatasvir; Voxilaprevir appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Sofosbuvir; Velpatasvir; Voxilaprevir1 dosage-form group in the Orange Book
0generic makers listed
  1. Sofosbuvir; Velpatasvir; Voxilaprevir appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Vosevi. No generic is listed as marketed.

20152020202520302035204001brand 2017data datePatent 9085573 listed to expire 21 March 2028Patent 8334270 listed to expire 21 March 2028Patent 8580765 listed to expire 21 March 2028Patent 8735372 listed to expire 21 March 2028Patent 8957046 listed to expire 21 March 2028Patent 8580765*PED listed to expire 21 September 2028Patent 8334270*PED listed to expire 21 September 2028Patent 8735372*PED listed to expire 21 September 2028Patent 9085573*PED listed to expire 21 September 2028Patent 7964580 listed to expire 26 March 2029Patent 8889159 listed to expire 26 March 2029Patent 8633309 listed to expire 26 March 2029Patent 7964580*PED listed to expire 26 September 2029Patent 8633309*PED listed to expire 26 September 2029Patent 8889159*PED listed to expire 26 September 2029Patent 9284342 listed to expire 13 September 2030Patent 8618076 listed to expire 11 December 2030Patent 9284342*PED listed to expire 13 March 2031Patent 8618076*PED listed to expire 11 June 2031Patent 8940718 listed to expire 16 November 2032Patent 8575135 listed to expire 16 November 2032Patent 8921341 listed to expire 16 November 2032Patent 9868745 listed to expire 16 November 2032Patent 8575135*PED listed to expire 16 May 2033Patent 8921341*PED listed to expire 16 May 2033Patent 8940718*PED listed to expire 16 May 2033Patent 11116783 listed to expire 30 January 2034Patent 9296782 listed to expire 17 July 2034Patent 11116783*PED listed to expire 30 July 2034Patent 11338007 listed to expire 1 June 2037Patent 10912814 listed to expire 1 June 2037Patent 11338007*PED listed to expire 1 December 2037
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 21 March 2028Patent 9085573 drug substance
  • 21 March 2028Patent 8334270 drug substance
  • 21 March 2028Patent 8580765 drug substance
  • 21 March 2028Patent 8735372 drug substance
  • 21 March 2028Patent 8957046
  • 21 September 2028Patent 8580765*PED
  • 21 September 2028Patent 8334270*PED
  • 21 September 2028Patent 8735372*PED

24 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.